India inspects drug factories as Gambia controversy lingers

India is known as the "pharmacy of the world" and its pharmaceuticals exports have more than doubled over the past decade to $24.5 billion in the past fiscal year. The deaths of at least 70 children in Gambia has dented the industry's image, though India says the drugs made by New Delhi-based Maiden Pharmaceuticals Ltd were not at fault.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HkwEazZ
via IFTTT